Early Mobilization After Pacemaker Implantation. (EMAPI)

August 17, 2023 updated by: Jiri Smid, Charles University, Czech Republic
Permanent pacemaker implantation is one of the most common arrhythmological procedure. This procedure is usually accompanied by a minimum of 2-3 days hospitalization, with immobilization of patients (supine) for 16-24 hours. The optimal duration of patient´s immobilization is not determined. There is also no recommendation from individual manufacturers of pacemakers for the duration of immobilization after pacemaker implantation. The length of immobilization is based rather on the tradition established at the time of using electrodes with passive fixation. The aim of our prospective, randomized study (EMAPI) is to compare the safety of short-term (4-hours) immobilization with long-term (16-24 hours) immobilization after primary pacemaker implantation. Septal position will be used for right ventricular electrode.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Plzen, Czechia, 32300
        • Jiri Smid, Cardiology department, University Hospital and Faculty of Medicine in Pilsen, Charles University, Czech Republic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. 18 years and older.
  2. Indication for permanent pacemaker implantation.
  3. Mobile and compliant patient.
  4. Willing and able to give written informed consent.

Exclusion Criteria:

  1. Imobile and noncompliant patient.
  2. Indication of CRT implantation.
  3. Upgrade or revision of implanted devise.
  4. Contraindications to pacemaker implantation.
  5. Gravidity.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Short-term (4-hours) immobilization.
Short-term (4-hours) immobilization after primary pacemaker implantation.
Pacemaker implantation
Active Comparator: Long-term (16-24 hours) immobilization.
Long-term (16-24 hours) immobilization after primary pacemaker implantation.
Pacemaker implantation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Composite endpoint of incidence of adverse events from secondary outcomes depending on the length of immobilization (early vs. late).
Time Frame: 6 months
Comparsion of incidence of dislodgement of atrial electrode, dislodgement of ventricular electrode in septal position, hematoma surgically treated or requiring blood transfusions, pneumothorax, pocket infection, others complications
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of atrial lead dislodgement.
Time Frame: 6 months
comparsion of early vs. late mobilization
6 months
Incidence of ventricular lead dislodgement.
Time Frame: 6 months
comparsion of early vs. late mobilization
6 months
Incidence of hematoma (surgically treated or requiring blood transfusions.)
Time Frame: 6 months
comparsion of early vs. late mobilization
6 months
Incidence of pneumothorax.
Time Frame: 24 hours
comparsion of early vs. late mobilization
24 hours
Incidence of pocket infection.
Time Frame: 6 months
comparsion of early vs. late mobilization
6 months
Incidence of others complications.
Time Frame: 6 months
comparsion of early vs. late mobilization, (mechanical, extracardiac complication etc.)
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 28, 2019

Primary Completion (Estimated)

December 1, 2023

Study Completion (Estimated)

February 1, 2024

Study Registration Dates

First Submitted

September 6, 2019

First Submitted That Met QC Criteria

September 30, 2019

First Posted (Actual)

October 1, 2019

Study Record Updates

Last Update Posted (Actual)

August 21, 2023

Last Update Submitted That Met QC Criteria

August 17, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Early mobilization 14-3-2019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pacemaker Complication

Clinical Trials on Pacemaker implantation

3
Subscribe